% | $
Quotes you view appear here for quick access.

Organovo Holdings, Inc. Message Board

  • m58851 m58851 Nov 2, 2013 8:52 AM Flag

    Revenue stream ....

    ONVO is years away from a continuous revenue stream however small. Lots of secondary dilutions before any major revenue stream. The technology, however, seems good and patent protected. Best scenario: a buyout by a major pharma. Many current investors will see greener pastures and bail resulting in a near-term selloff to $6.50 - $6.80. If you're long, just stay put but don't expect mid $8s for a long time but $10s-$12s in a couple of years. Monday see a surge to $7.60s and selloff to around $7.30s end of day with range of $7.09-$7.62 during the week. GLTA. (Off record: see GALE and do DD, near 50-day moving average and a 5-7% pop next week.-ultiple catalysts in near term including results of launch of ABSTRAL end of month.)(Late stage results of signature drug soon.)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.71-0.12(-4.24%)May 3 4:00 PMEDT